Wahi, Nor-kaifa .

HRN: 26-92-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2025
CEFTRIAXONE 1G (VIAL)
04/07/2025
04/14/2025
IV
450 Mg
Q24hrs
Sepsis
Waiting Final Action 
04/07/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/07/2025
04/14/2025
IV
35mg
Q6h
Scabies With Secondary Bacterial Infection
Waiting Final Action 
04/12/2025
OXACILLIN 500MG (VIAL)
04/12/2025
04/18/2025
IV
115mg
Q6
Bacterial Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: